1 make the interesting observation that it is possible to repeatedly immunize mice in ways that allow for development of high numbers of memory CD8 T cells without depleting pre-existing memory cells specific for other pathogens. This study, which offers promise in developing potent vaccination schemes, is seemingly at odds with work published by us in the 1990s showing a loss in CD8 memory cells after a series of infections 2, 3 . In their reply, Vezys et al. mention that we may have misinterpreted our data because we reported the putative loss of memory T cells as per cent rather than total number, but here we represent the data in those studies as total cell number [2] [3] [4] . We show here in Fig. 1 that a series of infections can indeed reduce the total number of memory cells, indicating that vaccination strategies need to consider this issue.
Figure 1a portrays limiting dilution assay data, a measure mostly of central memory cells, with 3 to 11 determinations per group, and Fig. 1b shows determinations with intracellular cytokine and MHCdimer assays, with 6 determinations per group. They show that losses in memory CD8 cells became statistically significant after a series of viral infections. Virus-induced losses in total body memory have also been reported by in vivo cytotoxicity assays, which monitor the ability of T cells to kill antigen-expressing targets in the host 5 . Others have reported bacteria-induced losses of T-cell-dependent immunity to tumours 6 . These findings differ with the conclusions of Vezys et al. 1 , who examined loss of memory cells after infections with only a single pathogen or after a series of immunizations with vectors encoding the same antigen in a prime-boost immunization scheme.
The relevance of that point rests on the observation that virusinduced type 1 interferon (IFN) mediates high levels of apoptosis of memory T cells early during infections [7] [8] [9] [10] . We previously addressed the question of whether the long-term loss of memory cells was a function of this early apoptosis (active attrition) or due to a competition model for niches in the immune system (passive attrition), and concluded that most of the loss in memory cells could be accounted for by active attrition rather than competition 5 . We question whether the prime-boost immunization scheme of Vezys et al. would elicit the apoptosis-inducing levels of type 1 IFN that a series of different viruses would, because the homologous immunity elicited to their immunizing antigen inserts would inhibit replication of the vectors. Furthermore, recombinant vaccinia virus like that used in this study is a poor IFN inducer. A recent paper 11 reports a substantial type 2 IFN (IFN-c)-dependent permanent loss of memory CD8 T cells in mice challenged with intracellular bacteria that were strong IFN-c (but not type 1 IFN) inducers. There it was also concluded 11 that the loss of memory cells was due to an active process and not due to competition. This indicates that more than one class of IFN can cause memory T-cell attrition.
Vezys et al. 1 state that an argument for memory CD8 T-cell stability is a human study showing a half-life of 8-16 years for vaccinia-virusspecific CD8 T cells 12 . However, that same study could not detect vaccinia-virus-specific CD8 T cells in 50% of the subjects vaccinated over 20 years earlier. We contend that those data are more consistent with a loss in human memory T cells than of memory cell stability.
We therefore argue that the study of Vezys et al. 1 does not refute earlier work showing that a series of infections depletes splenic memory CD8 cells specific to previously encountered pathogens. It does, however, nicely show how one can avoid such depletion by using a prime-boost immunization scheme with vectors that are not strong IFN inducers. We reported that it is possible to increase the total number of memory CD8 T cells within an organism, and to establish preternatural numbers of vaccine-specific effector memory CD8 T cells while preserving naive CD8 T cells and most pre-existing memory CD8 T cells specific for a previously encountered infection 1 . These findings raise new questions regarding the regulation and limits of generating CD8 T cell immunity. Our discussion highlighted three points related to the issue of attrition. First, that it is possible to over-estimate perceived attrition by only examining percentages (see Fig. 1 of ref. 1) 2 . Second, our vaccine regimen resulted predominantly in the generation of effector memory CD8 T cells located outside of lymph nodes. It remains possible that the number of lymph node central memory T cells remains tightly regulated. Third, we noted that our data did not refute that attrition could happen under a variety of circumstances. However, our data demonstrate that attrition is not an axiomatic property of immunization, mandated by stringent regulation of the size of the total memory CD8 T-cell compartment. Indeed, we saw no evidence of attrition after single infections with a virus (vaccinia), an intracellular bacteria (Listeria monocytogenes) and a parasite that induces massive splenomegaly (Plasmodium yoelii), and observed comparatively little attrition after a heterologous prime-boost regimen involving successive immunization with three viruses 1 . The issue at hand is whether our results represent rare exceptions that could be exploited for vaccination, or whether preservation of immunological memory is a normal feature of the mammalian immune system. Welsh and Selin 2 argue that memory T-cell maintenance is regulated by the quantity of type 1 IFN produced in response to subsequent infections, and that most infections invariably lead to profound loss of pre-existing memory CD8 T cells. Data supporting this claim demonstrate that up to 25-90% of pre-existing memory CD8 T cells are lost after single infections, and that attrition accumulates further with each infection 3, 4 . Surprisingly, infection-specific naive and memory T cells were not spared 5 . The current model of Welsh and Selin 2 predicts that immunological memory must be short-lived in the face of occasional infections. Consequently, they question the evidence that CD8 T-cell memory specific for vaccinia has a long half-life in humans 6 . Memory CD8 T cells have also been examined after a single exposure to both measles and hantavirus, and robust populations could be detected .10 years later 7, 8 . Protective immunity against measles virus (for which T-cell memory may be important) persists .65 years (ref. 9) . Memory B cells persist indefinitely after smallpox immunization, and the half-life of serum antibody, which must be continuously produced by differentiated antigen-experienced B cells, ranges from 92 to 3,014 years after exposure to measles, mumps, rubella or vaccinia virus 10, 11 . These data indicate that immunological memory does not necessarily undergo rapid erosion, although further studies regarding the longevity of CD8 T memory are needed.
The concept advanced by our paper is that attrition is not an axiomatic property of immunization, and that the memory CD8 T-cell compartment is capable of expansion. In support of these findings, it was recently reported that primary human cytomegalovirus infection resulted in a long-lived increase in the total number of antigenexperienced CD8 T cells, and induced a reduction in the frequency, but not number, of pre-existing memory CD8 T cells specific for influenza or Epstein-Barr viruses in blood 12 . It should be stressed that immunity to certain agents (for example, after vaccination with nonreplicating agents) may be intrinsically prone to attrition, and certain infections may significantly erode immunological memory. These may include pathogens that infect lymphocytes, destroy lymphoid tissue or are associated with other pathologies, as indicated by Welsh 
